Trusted by experts.
Recognized for excellence.
Award-winning science that gives you clearermore actionable insights about you.
Our services
Ancestry Service
Basic Ancestry
Explore the unique story written in your DNAfrom your global ancestry breakdown out of 4,500+ regions to the relatives who share your genetic legacy.
23andMe+ Premium™
Advanced Ancestry + Health
Membership fueled by discoverysharpened by time. Provides 100+ genetic insights and action tools.
FSA & HSA Eligible
23andMe+ Total Health™
Ultimate Health + Advanced Ancestry
Our most advanced health kit. Includes next-generation DNA analyses and blood testing to provide cutting-edge longevity insights and guidance toward a healthier you.
FSA & HSA Eligible
* 23andMe+ Premium renews at $69 per year. Cancel anytime. 23andMe+ Total Health renews at $199 per year. Cancel anytime.
Connect the dots between pastpresentand future you.
Best in class genotyping experience combines the most comprehensive ancestry breakdown with 100+ health reports and insights. Plus ongoing information based on your DNA as the science becomes available.
23andMe+ Total Health
Total Health is a next gen longevity platform built with the tools to not only help you live more yearsbut to live more healthy years. Discover a new take on growing older.
Learn more about Total HealthThere’s more to your story.
Understand the larger context of where you come frombreaking down your ancestry to the 0.1%. It's the most comprehensive genetic breakdown on the markethelping you gain a more complete portrait of yourself.
Privacy by design
There is no advanced science that comes before your protection. Read more about our enhanced measures designed to keep your data safein any scenario.
Learn moreThings you might be wondering:
23andMe has rigorous standards that ensure high-quality results. Our team of scientists and medical experts use a robust process to develop genetic reports for our customers. Here are specific examples:
- With one of the largest reference datasets in the world23andMe provides customers with one of the most detailed and accurate ancestry breakdowns on the market. Our algorithms make ancestry estimates based on probabilities and they’re generally very accuratebut your results are not set in stone. We are always trying to improve and refine these estimates.
After you provide a saliva sample23andMe uses genotyping to analyze your DNA. This means we look at specific locations in your genome that are known to differ between people. We then turn those results into personalized genetic reports on everything from ancestry composition to traits to genetic health risks. Note that genotyping is different from DNA sequencingwhich looks at every letter in a particular stretch of DNA.
Most adults who are able to provide saliva samples can use the 23andMe kit. However there are some considerations that can complicate the DNA accuracy. Check out our Terms of Service for more info on those cases.
To beginvisit www.23andme.com/start. Once you have successfully registered your DNA testing kitprovided a saliva sample and put the kit in the mailyou can use the return tracking link available on your profile homepage to track your kit's progress to the lab. Once your sample reaches the labit is typically processed within a few weekswith results then delivered to your secure online account.
We encourage customers to provide their sample before the "Collect saliva by" date on the side of the collection tube. If your sample collection kit is lost or damagedor if it has expiredplease contact customer care to assist you with getting a replacement kit.
When it comes to understanding your DNA23andMe offers trusted insights built on years of scientific research and innovation. As a pioneer in personal genetic testingwe've helped millions of people worldwide learn more about their ancestrytheir health—and themselves.
We offer more than just ancestry breakdowns. Our genetic health services screen for up to 95+ conditionshelping you understand your personal health risks and predispositions. You can also gain insights into carrier status for family planningwellness and life factorsand how your body processes certain medications—empowering proactiveinformed health decisions. We're the first and only direct-to-consumer DNA service with multiple health reports with FDA clearancesetting the standard in genetic testing.
With one of the world's largest DNA databaseswe provide an unmatched level of detailaccuracyand discovery in our ancestry product. Our ancestry reports include 4,500+ geographic regions and the option to connect with DNA relativesmaking it the most comprehensive ancestry product on the market.
And if you decide to participate in our research programyou'll join millions of others helping advance discoveries in genetics and human health. It's a simple but meaningful way to make an impact in areas like Parkinson's diseasecancerdepressionand more. It's a unique opportunity to contribute to scientific progresssimply by participating from home.
Protecting your privacy and keeping your data secure are top priorities at 23andMe. We're committed to being transparent and giving you clear choices about how your information is used.
So why choose 23andMe? Because it's more than a test. It's a trusted path to self-discoverybacked by scienceand built for you.
Your DNA holds powerful information about your healthancestryand traits—and at-home genetic testing puts that knowledge in your hands.
Most people who carry a serioushighly actionable genetic variant don't even know it. In factabout 90% go undetected through standard doctor visits alone. An at-home genetic test like 23andMe can uncover important health insights that might otherwise remain hiddengiving you the opportunity to take proactive stepsask better questionsand make more informed decisions.
Unlike traditional medical testingat-home genetic testing is simpleaccessibleand done entirely from home. You don't need a referral or a clinic appointment to start learning about your genetic makeup. And with 23andMe premium subscription servicesyou're not just getting a one-time snapshotyou're gaining ongoing access to new science-backed reports on everything from inherited health conditions to traits and ancestry.
Personal genetic testing is about empowerment. It's about understanding your risksdiscovering your rootsand gaining clarity about how your genes may impact your lifeas well as your family's.
When you can access this kind of information directlyyou're in a better position to advocate for your healthyour choicesand your future.
Stay in the know.
Keep up-to-date with new discoveries and exclusive promotions on our DNA testing kits and services.
**The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a diseasebut does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of healthor to be used to make medical decisionsincluding whether or not you should take a medicationhow much of a medication you should takeor determine any treatment. Our carrier status reports can be used to determine carrier statusbut cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the futurethe health of your fetusor your newborn child's risk of developing a particular disease later in life. For certain conditionswe provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of 44 variants in the BRCA1 and BRCA2 genes. The report describes if a person's genetic result is associated with an increased risk of developing breast cancer and ovarian cancer and may be associated with an increased risk for prostate cancerpancreatic cancerand potentially other cancers. The variants included in this report do not represent the majority of the BRCA1/BRCA2 variants in people of most ethnicities. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. This report is for over-the-counter use by adults over the age of 18and provides genetic information to inform discussions with a healthcare professional. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status reportvisit 23andme.com/test-info/
***23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Our SLCO1B1 Pharmacogenetics report provides certain information about variants associated with the processing of some therapeutics and provides interpretive drug information regarding the potential effect of simvastatin therapy. Our DPYD Pharmacogenetics report does not describe the association between detected variants and any specific therapeutic. Results for DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to startstopor change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medicationtherefore consult with your healthcare professional before taking any medical action. For important information and limitations regarding Pharmacogenetic reportsvisit 23andme.com/test-info/pharmacogenetics/
triangleExome Sequencing and blood testing services are available to eligible customers upon completion of the intake questionnaire that must be reviewedapproved and ordered by a third-party clinician. Exome Sequencing is analyzed by a CLIA- and CAP-accredited laboratory. Blood testing is completed by Quest Diagnostics. All telehealth services are provided in accordance with the Telehealth Terms and Consent to Telehealth.